Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hartmut Knönagel

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Praxis|February 8, 2017
Jan Tuma, Hartmut Knönagel
Praxis|February 18, 2017
Jan Tuma, Hartmut Knönagel
Urologia Internationalis|April 29, 2011
Thermal spread of vessel-sealing devices evaluated in a clinically relevant in vitro modelDaniel Eberli, Lukas J Hefermehl, Alexander Müller, et al.
Expert Review of Medical Devices|October 27, 2011
Electrosurgery in urology: recent advancesMathias Tremp, Lukas Hefermehl, Remo Largo, et al.
European Urology|January 15, 2008
Using PSA to guide timing of androgen deprivation in patients with T0-4 N0-2 M0 prostate cancer not suitable for local curative treatment (EORTC 30891)Urs E Studer, Laurence Collette, Peter Whelan, et al.
European Urology|August 13, 2013
Differences in time to disease progression do not predict for cancer-specific survival in patients receiving immediate or deferred androgen-deprivation therapy for prostate cancer: final results of EORTC randomized trial 30891 with 12 years of follow-upUrs E Studer, Peter Whelan, Florian Wimpissinger, et al.
The Journal of Pathology|December 4, 2003
High-throughput tissue microarray analysis of 11q13 gene amplification (CCND1, FGF3, FGF4, EMS1) in urinary bladder cancerBoriana M Zaharieva, Ronald Simon, Pierre-Andre Diener, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Praxis|February 8, 2017
Jan Tuma, Hartmut Knönagel
Praxis|February 18, 2017
Jan Tuma, Hartmut Knönagel
Urologia Internationalis|April 29, 2011
Thermal spread of vessel-sealing devices evaluated in a clinically relevant in vitro modelDaniel Eberli, Lukas J Hefermehl, Alexander Müller, et al.
Expert Review of Medical Devices|October 27, 2011
Electrosurgery in urology: recent advancesMathias Tremp, Lukas Hefermehl, Remo Largo, et al.
European Urology|January 15, 2008
Using PSA to guide timing of androgen deprivation in patients with T0-4 N0-2 M0 prostate cancer not suitable for local curative treatment (EORTC 30891)Urs E Studer, Laurence Collette, Peter Whelan, et al.
European Urology|August 13, 2013
Differences in time to disease progression do not predict for cancer-specific survival in patients receiving immediate or deferred androgen-deprivation therapy for prostate cancer: final results of EORTC randomized trial 30891 with 12 years of follow-upUrs E Studer, Peter Whelan, Florian Wimpissinger, et al.
The Journal of Pathology|December 4, 2003
High-throughput tissue microarray analysis of 11q13 gene amplification (CCND1, FGF3, FGF4, EMS1) in urinary bladder cancerBoriana M Zaharieva, Ronald Simon, Pierre-Andre Diener, et al.
Pageof 1